ZEN INVESTING
zen investing
NVIDIA NIM Enhances Curation of Biological Insights with AI
NVIDIA NIM, in collaboration with CytoReason, leverages AI to expedite the extraction of biological insights from scientific literature, significantly reducing processing time while maintaining high accuracy.
zen investing
Revolutionizing Antibody Development: AlphaBind Leverages NVIDIA and AWS
AlphaBind, developed by A-Alpha Bio, employs NVIDIA and AWS technologies to enhance antibody-antigen binding predictions, aiming to revolutionize biologics development.
zen investing
NVIDIA: EvolutionaryScale Unveils ESM3 Generative AI Model for Protein Design
EvolutionaryScale launches ESM3, an advanced AI model for protein design, leveraging NVIDIA's H100 GPUs to accelerate biological research.